Turkey's Palliative care market is projected to grow from $104.64 Mn in 2022 to $200.97 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, the rising prevalence of chronic diseases and growing awareness. The market is segmented by service type and by the end user. Some of the major players include Anadolu Medical Center Oncology, Hisar Hospital, Medical Park Group and American Hospital.
Turkey's Palliative care market is projected to grow from $104.64 Mn in 2022 to $200.97 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022 - 2030. In 2019, Turkey's national healthcare spending as a percentage of GDP was 4.34%, amounting to $396 per person. Turkish health expenditures per person rose from 154 USD in 2001 to 571 USD in 2008, although they fell by an average of 1.81% each year between 2008 and 2019.
Enhancing the quality of life for patients and their families who are dealing with a terminal illness is the aim of palliative care. It prevents and lessens suffering through early detection, precise diagnosis, and efficient treatment of pain and other disorders, whether they are physical, psychosocial, or spiritual. Taking care of issues that go beyond physical sensations is a component of happiness. A team approach is used in palliative care to support patients and their carers. This includes providing for practical needs and providing bereavement counselling. It offers a support system that enables patients to live as fully as possible up until their deaths.
The increased emphasis of major palliative care service providers on regional development into developing Asia-Pacific nations in order to obtain a substantial market share is expected to fuel the growth of the Asia-Pacific palliative care market.
Market Growth Drivers
Turkey's population is ageing rapidly, and this trend is predicted to continue in the future, which is helping the palliative care industry expand. As one of the main causes of death in Turkey, chronic diseases like cancer, cardiovascular disease, and neurological disorders also pose significant health risks and could benefit from palliative care treatments. The rise of the palliative care industry is also being driven by the rising awareness of and desire for high-quality end-of-life care among Turkish citizens.
Market Restraints
The lack of trained professionals and limited availability of palliative care services are restricting the market from expanding in the country. Moreover, in Turkey, palliative care services are frequently underfunded, which can lead to restricted access to necessary drugs, supplies, and services.
Key Players
The Ministry of Health in Turkey is in charge of governing the nation's healthcare system, which includes palliative care services. The public sector is the primary provider of healthcare services in Turkey's healthcare system, which combines private and public healthcare providers. To encourage the creation and provision of palliative care services in the nation, the Ministry of Health has created policies and laws.
The National Cancer Control Program (NCCP), which was established in 2008 to enhance national cancer care, is one of the main initiatives. The NCCP's comprehensive approach to cancer care includes palliative care services. To direct the growth of palliative care services throughout the nation, the Ministry of Health has also created a National Palliative Care Strategy.
The Ministry of Health, which establishes rules and regulations for healthcare services, including palliative care, regulates Turkey's healthcare system. Turkish hospitals and clinics receive the majority of their funding from the government through a national health insurance program.
Based on the type of service and the environment, different reimbursement regulations for palliative care exist in Turkey. Outpatient services are not yet covered by the national health insurance system, but inpatient palliative care services are. However, there have been recent initiatives to broaden coverage to include outpatient therapies, with some private health insurance providers now providing reimbursement for specific palliative care services.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Service Type (Revenue, USD Billion):
Based on service type, the Turkey palliative care market is divided into the following:
By End User (Revenue, USD Billion):
Based on end-user type, the Turkey palliative care market is divided into the following:
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.